1.72
price down icon18.10%   -0.38
after-market Handel nachbörslich: 1.67 -0.05 -2.91%
loading
Schlusskurs vom Vortag:
$2.10
Offen:
$2.01
24-Stunden-Volumen:
147.65M
Relative Volume:
2.02
Marktkapitalisierung:
$1.91B
Einnahmen:
$829.22M
Nettoeinkommen (Verlust:
$-248.96M
KGV:
-5.7333
EPS:
-0.3
Netto-Cashflow:
$-92.10M
1W Leistung:
+6.17%
1M Leistung:
+57.80%
6M Leistung:
+240.32%
1J Leistung:
+8.18%
1-Tages-Spanne:
Value
$1.71
$2.02
1-Wochen-Bereich:
Value
$1.51
$2.32
52-Wochen-Spanne:
Value
$0.3507
$2.32

Tilray Brands Inc Stock (TLRY) Company Profile

Name
Firmenname
Tilray Brands Inc
Name
Telefon
519.322.8800
Name
Adresse
655 MADISON AVENUE, NEW YORK
Name
Mitarbeiter
2,842
Name
Twitter
@tilray
Name
Nächster Verdiensttermin
2025-10-09
Name
Neueste SEC-Einreichungen
Name
TLRY's Discussions on Twitter

Vergleichen Sie TLRY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
TLRY
Tilray Brands Inc
1.72 2.33B 829.22M -248.96M -92.10M -0.30
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
141.11 63.55B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.71 44.47B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.00 40.17B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.03 22.99B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
440.00 20.14B 3.08B 1.24B 1.07B 25.61

Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-04-05 Bestätigt Alliance Global Partners Neutral
2022-11-02 Eingeleitet Bernstein Mkt Perform
2022-07-29 Herabstufung The Benchmark Company Hold → Sell
2022-03-04 Hochstufung Canaccord Genuity Hold → Buy
2021-11-18 Eingeleitet Barclays Underweight
2021-11-01 Herabstufung Cantor Fitzgerald Overweight → Neutral
2021-06-11 Herabstufung CIBC Sector Outperform → Neutral
2021-06-03 Hochstufung Cantor Fitzgerald Neutral → Overweight
2021-05-11 Fortgesetzt Cowen Outperform
2021-05-07 Fortgesetzt Jefferies Buy
2021-05-06 Eingeleitet Canaccord Genuity Buy
2021-04-28 Fortgesetzt BofA Securities Buy
2021-02-18 Herabstufung Piper Sandler Overweight → Neutral
2021-02-18 Herabstufung The Benchmark Company Buy → Hold
2020-11-16 Herabstufung Jefferies Hold → Underperform
2020-11-11 Herabstufung Stifel Hold → Sell
2020-10-01 Bestätigt MKM Partners Neutral
2020-09-21 Hochstufung Jefferies Underperform → Hold
2020-05-12 Bestätigt The Benchmark Company Buy
2020-04-16 Herabstufung Jefferies Hold → Underperform
2020-04-09 Herabstufung Consumer Edge Research Overweight → Equal Weight
2020-02-24 Herabstufung Cowen Outperform → Market Perform
2020-01-13 Eingeleitet BofA/Merrill Neutral
2019-11-13 Bestätigt The Benchmark Company Buy
2019-11-05 Eingeleitet Cantor Fitzgerald Neutral
2019-10-22 Bestätigt Piper Jaffray Overweight
2019-09-20 Eingeleitet MKM Partners Neutral
2019-08-14 Bestätigt The Benchmark Company Buy
2019-07-17 Eingeleitet Ladenburg Thalmann Neutral
2019-06-28 Eingeleitet Consumer Edge Research Overweight
2019-06-06 Eingeleitet Stifel Hold
2019-06-05 Eingeleitet Oppenheimer Perform
2019-05-15 Hochstufung BMO Capital Markets Underperform → Market Perform
2019-05-13 Eingeleitet Alliance Global Partners Neutral
Alle ansehen

Tilray Brands Inc Aktie (TLRY) Neueste Nachrichten

pulisher
Oct 10, 2025

Promising Cannabis Stocks To Follow NowOctober 10th - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Tilray (TLRY) Stock Down After New Share Offering - GuruFocus

Oct 10, 2025
pulisher
Oct 10, 2025

Tilray Brands (TSE:TLRY) Trading Down 12.6%Time to Sell? - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Why Tilray Brands Stock Just Stubbed Out - AOL.com

Oct 10, 2025
pulisher
Oct 10, 2025

Tilray Brands (NASDAQ:TLRY) Shares Gap DownHere's Why - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Cannabis Market Trends and Company Analysis 2025-2033 - GlobeNewswire

Oct 10, 2025
pulisher
Oct 10, 2025

Cannabis Market Trends and Company Analysis 2025-2033 Featuring Canopy Growth, Tilray Brands, Curaleaf, Aurora, Jazz Pharma, Green Thumb Industries, Trulieve, Cresco Labs, Organigram, TerrAscend - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

Tilray Brands Inc. stock trendline breakdownPortfolio Performance Summary & Consistent Growth Equity Picks - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Tilray (TLRY) Stock: Cannabis Company Stuns Wall Street with Earnings Beat - parameter.io

Oct 10, 2025
pulisher
Oct 10, 2025

Tilray Earnings: Decent Performance in Cannabis and Alcohol - Morningstar

Oct 10, 2025
pulisher
Oct 10, 2025

Tilray Reports Strong Q1-2026 Earnings As The Cannabis Sector Rallies (TLRY) - Seeking Alpha

Oct 10, 2025
pulisher
Oct 10, 2025

Small caps to watch: MTY Food Group, Richelieu Hardware, Linamar, Tilray, and more - The Globe and Mail

Oct 10, 2025
pulisher
Oct 10, 2025

Delta, Pepsi, Applied Digital, Levi's, Tilray Brands kick off Q3 earnings season - Proactive financial news

Oct 10, 2025
pulisher
Oct 10, 2025

Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Friday; Applied Digital to Rise, Tilray Brands to Fall - MarketScreener

Oct 10, 2025
pulisher
Oct 10, 2025

Pattern recognition hints at Tilray Brands Inc. upsideTrade Exit Report & Community Consensus Picks - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Stock Market Today: Tilray Brands Soars After Earnings Beat - AOL.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will Tilray Brands Inc. stock go up soonTrade Entry Summary & Safe Capital Allocation Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

TLRY Q3 Deep Dive: Cannabis, Beverage, and Wellness Diversification Drive Operating Turnaround - FinancialContent

Oct 10, 2025
pulisher
Oct 10, 2025

Tilray Brands (NASDAQ:TLRY) Stock Price Up 22.1%Here's Why - MarketBeat

Oct 10, 2025
pulisher
Oct 09, 2025

Tilray Brands Reports Record Revenue and Profitability - TipRanks

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Brands (TLRY) Hits All-Time High on Stellar Q1 Earnings - MSN

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Soars 22%, Time to Buy Pot Stocks? - NAI500

Oct 09, 2025
pulisher
Oct 09, 2025

How Recent Developments Are Rewriting the Story for Tilray Brands - Yahoo Finance

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Brands (TSE:TLRY) Stock Price Up 28.6%What's Next? - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray (TLRY): Five-Year Losses Increase 31.4% Annually, Profit Remains Elusive Heading Into Earnings - simplywall.st

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Brands FY26-Q1 10-Q Review (NASDAQ:TLRY) - Seeking Alpha

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Brands (TLRY) Files Mixed Securities Shelf - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Brands files automatic mixed securities shelf - MSN

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Brands Inc files for mixed shelfSEC filing - MarketScreener

Oct 09, 2025
pulisher
Oct 09, 2025

Stock Market Today: Tilray Brands Soars After Earnings Beat - The Motley Fool

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Brands, Inc. SEC 10-Q Report - TradingView

Oct 09, 2025
pulisher
Oct 09, 2025

Stocks to Watch Thursday: PepsiCo, MP Materials, Tilray Brands, Nvidia - The Wall Street Journal

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Brands (NASDAQ:TLRY) Hits New 52-Week HighTime to Buy? - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Brands (TLRY) Stock Surges on Strong Quarterly Earnings - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Beverage Revenue ‘Flat’ at $55.7M in Q1; Overall Net Revenue +5%, to ‘Record’ $209.5M - BevNET.com

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray (TLRY) Stock Surges To New 52-Week High On Strong Q1 Earnings ReportTilray Brands (NASDAQ:TLRY) - Benzinga

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Just Shocked Wall Street--And the Stock Took Off Like a Rocket - Yahoo

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Brands (TLRY) Achieves Record Q1 Revenue and Strengthens Financial Position - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Brands Inc (TLRY) Q1 2026 Earnings Call Highlights: Strategic Expansions and Market ... - Yahoo Finance

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Brands Inc (TLRY) Q1 2026 Earnings Call Highlights: Strat - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

Why Tilray Brands Stock Glows Green Today - MSN

Oct 09, 2025
pulisher
Oct 09, 2025

Delta Air Lines, Tilray Brands, UiPath, Akero Therapeutics, Apogee Therapeutics: Stocks Making The Biggest Moves Today - Stocktwits

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray Brands Inc (TLRY) Q1 2026 Earnings Call Highlights: Strategic Expansions and Market ... By GuruFocus - Investing.com Canada

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray reaffirms $62M-$72M adjusted EBITDA guidance as international cannabis and beverage integration progress - MSN

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray stock: why options data is skewed to downside despite solid Q1 earnings - Invezz

Oct 09, 2025
pulisher
Oct 09, 2025

Cannabis Stocks To Watch TodayOctober 9th - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray isn't sacrificing efficiency on its beer brands, CEO says - Yahoo Finance

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray: Another Blah Quarter (NASDAQ:TLRY) - Seeking Alpha

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray (TLRY) Stock Surges After Q1 Revenue Beat Amid Investor Caution - Azat TV

Oct 09, 2025
pulisher
Oct 09, 2025

Why Are Tilray (TLRY) Shares Soaring Today - Yahoo Finance

Oct 09, 2025
pulisher
Oct 09, 2025

Tilray (TLRY) Q1 2026 Earnings Call Transcript - Mitrade

Oct 09, 2025

Finanzdaten der Tilray Brands Inc-Aktie (TLRY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Tilray Brands Inc-Aktie (TLRY) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Merton Carl A
Chief Financial Officer
Jul 31 '25
Option Exercise
0.58
93,928
54,478
970,279
Gendel Mitchell
Global General Counsel
Jul 31 '25
Option Exercise
0.58
93,928
54,478
742,069
Gendel Mitchell
Global General Counsel
Jul 31 '25
Buy
0.58
6,000
3,496
698,287
FALTISCHEK DENISE M
Chief Strategy Officer
Jul 31 '25
Option Exercise
0.58
93,928
54,478
874,564
FALTISCHEK DENISE M
Chief Strategy Officer
Jul 30 '25
Option Exercise
0.61
261,194
159,328
919,069
Herhalt Johann Michael
Director
Jul 30 '25
Option Exercise
0.61
124,378
75,871
239,930
Looney Thomas P.
Director
Jul 30 '25
Option Exercise
0.61
124,378
75,871
354,416
Hopkinson David G.
Director
Jul 30 '25
Option Exercise
0.61
124,378
75,871
335,563
Clanachan David F
Director
Jul 30 '25
Option Exercise
0.61
124,378
75,871
236,880
Persofsky Renah
Director
Jul 30 '25
Option Exercise
0.61
124,378
75,871
199,726
$19.76
price down icon 1.54%
$9.74
price down icon 2.50%
$53.95
price down icon 7.38%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.20%
$136.63
price down icon 1.33%
$440.00
price down icon 1.21%
Kapitalisierung:     |  Volumen (24h):